MAPT and Alzheimer disease: Patients with aMCI may show early signs of AD neuropathological attributes, such as hippocampal shrinkage, neurofibrillary tangles (NFT; aggregates of hyperphosphorylated tau) and Aβ40/42 accumulation, according to a systematic review (Stephan et al., 2012).